Cosmos Health Inc. announced that its antimicrobial skin cleanser, C‑Scrub Wash Chlorhexidine 4%, will be sold in Tesco’s UK stores beginning February 18 2026. The move places the product on the shelves of the country’s largest grocery retailer, which commands approximately 28‑30% of the UK grocery market and serves millions of customers each week.
The partnership is part of Cosmos Health’s broader strategy to grow its proprietary nutraceutical and over‑the‑counter portfolio in high‑margin markets. By securing placement in Tesco’s extensive network of more than 3,000 stores and its online platform, the company gains a powerful distribution channel that can accelerate sales momentum and support future product rollouts from its portfolio, such as Sky Premium Life and Mediterranation.
For investors, the Tesco deal signals a tangible expansion of Cosmos Health’s retail reach, potentially driving incremental revenue and reinforcing the company’s vertically integrated model. The partnership also demonstrates confidence from a major retailer in the quality and demand for Cosmos Health’s products, which could open doors to additional retail opportunities across Europe.
Cosmos Health’s CEO Greg Siokas noted that “C‑Scrub’s entry into Tesco represents a pivotal moment for Cosmos. Building on our established online presence with Amazon, securing placement with the UK’s largest retailer significantly enhances our retail presence and strengthens our credibility in the market.” The quote underscores the strategic importance of the partnership for expanding market reach and brand credibility.
While the announcement is positive, Cosmos Health continues to face financial challenges, reporting a net loss of $5.4 million and a net profit margin of –31.3% in Q3 2025. The Tesco partnership is a step toward improving sales volume, but the company’s overall profitability remains under pressure from ongoing losses and negative margins.
The launch also positions Cosmos Health to better compete in the UK’s competitive antimicrobial skin cleanser market, where other brands vie for shelf space in large retailers. By securing a high‑visibility channel, Cosmos Health can leverage Tesco’s customer base to drive demand for its broader product line.
The partnership is expected to enhance Cosmos Health’s brand credibility and could serve as a springboard for further European retail expansion, aligning with the company’s long‑term growth strategy.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.